Three physicians have earned the annual Bruce and Cynthia Sherman Charitable Foundation Sherman Prizes, which recognize excellence in the field of inflammatory bowel diseases.
The 2024 Sherman prize honorees include Millie Long, MD, interim division chief, professor of medicine and director of the fellowship program in the division of gastroenterology and hepatology at the University of North Carolina School of Medicine in Chapel Hill and Dermot McGovern, director of translational medicine at the F. Widjaja Inflammatory Bowel Disease Institute, director of the Precision Medicine Initiative, professor of medicine and biomedical sciences and Joshua L. and Lisa Z. Greer endowed chair in IBD genetics at Cedars-Sinai in Los Angeles.
Jordan Axelrad, MD, associate professor in the department of medicine at the New York University Grossman School of Medicine and co-director of the Inflammatory Bowel Disease Center at NYU Langone Health in New York City, was named the Sherman Emerging Leader Prize Honoree, according to a Sept. 18 news release sent to Becker's.
Dr. Long was awarded a $100,000 prize for innovating new practices in IBD prevention and leading advances in research, clinical care and education. She specializes in IBD prevention, and leads efforts to prevent complications of IBD and the medicines used to treat the diseases.
Dr. McGovern was awarded a $100,000 prize for applying his genetics and GI expertise to accelerate the development of personalized medicines and address healthcare disparities around the world.
Dr. Axelrad was awarded the $25,000 Sherman Emerging Leader Prize for his research on medication safety, therapeutic response and IBD triggers, as well as for his contributions to building an internationally recognized IBD Center.